Roche Holding AG (RHHBY)
OTC
Closed
Sep 21, 2026
Day's Range
55.0952 wk Range
39.50Overview - RHHBY - Roche Holding AG
Key Statistics
Valuation
Enterprise Value
461.00B
P/E (Trailing)
‪23.22‬
P/E (Forward)
‪16.24‬
PEG Ratio
‪16.24‬
Price / Sales (TTM)
‪5.54‬
Price / Book
‪8.65‬
EV / EBITDA
‪15.72‬
Profitability
Profit Margin
‪19.60%‬
Operating Margin
‪36.20%‬
Return on Assets
‪13.50%‬
Return on Equity
‪38.10%‬
Ownership
Shares Outstanding
796.76M
Float
5.23B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.52%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪54.42‬
200-Day Avg
‪52.84‬
Dividends
Payout Ratio
‪64.69%‬
Frequency
Annual
Analyst Consensus
8 analysts
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - RHHBY - Roche Holding AG
Peers - RHHBY - Roche Holding AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
Profile Summary - RHHBY - Roche Holding AG
About
Roche Holding AG is a leading pharmaceutical and diagnostics company based in Basel, Switzerland. As a pioneer in personalized healthcare, Roche dedicates itself to improving patient outcomes through scientific innovation and collaboration. Its pharmaceutical division focuses on developing drugs for oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
